APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $260,637 | -66.2% | 2,861 | -74.7% | 0.02% | -39.3% |
| Q3 2022 | $771,000 | +175.4% | 11,293 | +154.7% | 0.03% | +250.0% |
| Q2 2021 | $280,000 | -57.6% | 4,434 | -71.2% | 0.01% | -52.9% |
| Q1 2021 | $660,000 | +411.6% | 15,391 | +289.1% | 0.02% | +142.9% |
| Q2 2020 | $129,000 | +37.2% | 3,956 | +12.8% | 0.01% | +16.7% |
| Q1 2020 | $94,000 | +1466.7% | 3,508 | +1654.0% | 0.01% | – |
| Q4 2019 | $6,000 | -96.2% | 200 | -98.3% | 0.00% | -100.0% |
| Q4 2018 | $156,000 | – | 11,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |